A novel epigenetic driver and actionable target in castration-resistant prostate cancer

被引：0
|
作者：
Cacciatore, A. [1 ]
Sandrini, G. [1 ]
Musumeci, C. [1 ]
Guarrera, L. [2 ]
Albino, D. [1 ]
Bolis, M. [2 ]
Catapano, C., V [1 ]
Carbone, G. M. [1 ]
机构：
[1] Inst Oncol Res, Prostate Canc Biol Grp, Bellinzona, Switzerland
[2] Ist Ric Farmacol Mario Negri, Dept Computat Oncol, Milan, Italy
来源：
EUROPEAN UROLOGY | 2023年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A1157
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Kaiso as a novel therapeutic target in castration-resistant prostate cancer
    Lin, Huixian
    Wang, Honghe
    White, Jason
    Karanam, Balasubramanyam
    Ghebremedhin, Anghesom
    Adu-Addai, Benjaminal
    Grizzle, William
    Yates, Clayton
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [2] Catalase as a novel drug target for metastatic castration-resistant prostate cancer
    Giginis, Frantzeska
    Wang, Joshua
    Chavez, Aaron
    Martins-Green, Manuela
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (06): : 2644 - +
  • [3] Kaiso as a novel therapeutic target in castration-resistant prostate cancer (CRPC)
    Lin, Hui-Xian
    Wang, Honghe
    White, Jason
    Karanam, Balasubramanyam
    Ghebremedhin, Anghesom
    Addai, Benjamin Adu
    Grizzle, William E.
    Yates, Clayton
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Novel treatments for castration-resistant prostate cancer
    Sternberg, Cora N.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S195 - S199
  • [5] Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer
    Twiddy, Alexis L.
    Leon, Carlos G.
    Wasan, Kishor M.
    PHARMACEUTICAL RESEARCH, 2011, 28 (03) : 423 - 437
  • [6] Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer
    Alexis L. Twiddy
    Carlos G. Leon
    Kishor M. Wasan
    Pharmaceutical Research, 2011, 28 : 423 - 437
  • [7] ONECUT2 is a novel target for treatment of castration-resistant prostate cancer
    Joglekar, Tejashree
    Lin, Jianqing
    Shibata, Maho
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (02) : 89 - 90
  • [8] BET bromodomain inhibitors-A novel epigenetic approach in castration-resistant prostate cancer
    Lochrin, Sarah E.
    Price, Douglas K.
    Figg, William D.
    CANCER BIOLOGY & THERAPY, 2014, 15 (12) : 1583 - 1585
  • [9] Novel Strategies for Treating Castration-Resistant Prostate Cancer
    Leung, David Ka-Wai
    Chiu, Peter Ka-Fung
    Ng, Chi-Fai
    Teoh, Jeremy Yuen-Chun
    BIOMEDICINES, 2021, 9 (04)
  • [10] Novel agents for the management of castration-resistant prostate cancer
    Haddad, Housam
    Garcia, Jorge A.
    CURRENT OPINION IN UROLOGY, 2012, 22 (03) : 175 - 182
12345